Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
STRECK, INC. v. Ravgen, Inc.
Case Number:
Case Type:
IPR
Status:
Trial Instituted
Petitioner:
STRECK, INC.
Patent Owner:
Ravgen, Inc.
Tech Center:
1600
-
April 19, 2023
PTAB Upholds DNA Testing Patents Key To $272M Ravgen Win
The Patent Trial and Appeal Board has rejected biotechnology company Streck's contention that nearly 30 claims in a Ravgen genetic testing patent are obvious or anticipated, siding with the patent owner in yet another challenge to the testing system it had used to score $272 million in infringement damages in underlying litigation.
-
January 19, 2023
IP Forecast: Pfizer Wants Talks With FBI Kept Under Wraps
Pfizer is set to tell a Connecticut federal court next week that communications between its lawyers and the FBI shouldn't be disclosed in its trade secrets suit accusing former executives of stealing diabetes and cancer medication research. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.